Mulmit

Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals, Inc.

ZNTL Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-152,808,000-137,060,000-1.91
2024-12-3167,425,000-191,194,000-165,867,000-2.33
2023-12-310-299,509,000-292,305,000-4.47
2022-12-310-227,287,000-236,806,000-4.48

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-14WALTERS GROUP4,335,000
2026-06-16Kariuki Enoch57,100
2026-06-16Skvarka Jan57,100
2026-06-16Johnson David Michael57,100
2026-06-16Walker Luke Nathaniel57,100
2026-06-16Myers Scott Dunseth57,100
2026-05-26Campbell Shannon114,200
2026-02-10Vultaggio VincentPAO and PFO6,894
2026-02-09Vultaggio VincentPAO and PFO3,379
2026-02-09Bruns IngmarChief Medical Officer335
2026-02-09EASTLAND JULIA MARIECEO & President889
2026-02-06Vultaggio VincentPAO and PFO29,951

8-K events

FiledItems
2026-08-14Other events · Financial statements and exhibits
2026-08-06Results of operations · Regulation FD disclosure
2026-06-18Submission of matters to a vote
2026-05-27Officer or director change
2026-05-21Regulation FD disclosure · Other events
2026-05-12Results of operations · Regulation FD disclosure
2026-05-05Regulation FD disclosure · Other events
2026-04-17Regulation FD disclosure
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…